Literature DB >> 33034932

Epithelioid hemangioma of bone harboring FOS and FOSB gene rearrangements: A clinicopathologic and molecular study.

Yusuke Tsuda1, Albert J H Suurmeijer2, Yun-Shao Sung1, Lei Zhang1, John H Healey3, Cristina R Antonescu1.   

Abstract

The diagnosis of epithelioid hemangioma (EH) remains challenging due to its rarity, worrisome histologic features, and locally aggressive clinical and radiographic presentation. Especially in the bone, EH can be misdiagnosed as a malignant vascular neoplasm due its lytic, often destructive or multifocal growth, as well as atypical morphology. The discovery of recurrent FOS and FOSB gene fusions in the pathogenesis of most EH has strengthened its stand-alone classification, distinct from other malignant epithelioid vascular lesions, such as epithelioid hemangioendothelioma or angiosarcoma. In this study we investigate a group of molecularly confirmed skeletal EH by the presence of FOS or FOSB gene rearrangements to better define its clinical and pathologic characteristics within a homogenous molecular subset. The cohort included 38 patients (25 males, 13 females), with a mean age at diagnosis of 38 years (range, 4-75). Regional, multifocal presentation was noted in 10 cases. Only six cases were correctly recognized as EH by the referring institutions, while most were misdiagnosed as other vascular tumors. Of the 17 patients with follow-up data available, five patients (29%) developed local recurrence after marginal en bloc excision (n = 3) or curettage (n = 2). Local recurrence-free survival rates were 84% at 3 years and 38% at 5 years. No metastasis or disease-related death was identified. Imaging studies exhibited no specific features, showing cortical bone destruction and soft-tissue extension in 14 (38%) cases. FOS gene rearrangements were detected in 28 (74%) of cases, while FOSB rearrangements in 10 (26%) cases. Our results highlight the significant challenges encountered in establishing a correct diagnosis exclusive of the molecular testing, mainly due to its overlap to other malignant epithelioid vascular tumors. Skeletal EH emerges as a genetically defined locally aggressive vascular neoplasm, with a high rate of local recurrence, but lacking the propensity for distant spread.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  FOS; FOSB; epithelioid hemangioma; fusions

Mesh:

Substances:

Year:  2020        PMID: 33034932      PMCID: PMC7739373          DOI: 10.1002/gcc.22898

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  40 in total

1.  A mechanism for translationally coupled mRNA turnover: interaction between the poly(A) tail and a c-fos RNA coding determinant via a protein complex.

Authors:  C Grosset; C Y Chen; N Xu; N Sonenberg; H Jacquemin-Sablon; A B Shyu
Journal:  Cell       Date:  2000-09-29       Impact factor: 41.582

2.  Hemorrhagic epithelioid and spindle cell hemangioma: a newly recognized, unique vascular tumor of bone.

Authors:  S B Keel; A E Rosenberg
Journal:  Cancer       Date:  1999-05-01       Impact factor: 6.860

3.  Fusion events lead to truncation of FOS in epithelioid hemangioma of bone.

Authors:  David G P van IJzendoorn; Danielle de Jong; Cleofe Romagosa; Piero Picci; Maria Serena Benassi; Marco Gambarotti; Soeren Daugaard; Michiel van de Sande; Karoly Szuhai; Judith V M G Bovée
Journal:  Genes Chromosomes Cancer       Date:  2015-07-14       Impact factor: 5.006

4.  Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets.

Authors:  Evan Rosenbaum; Bhumika Jadeja; Bin Xu; Lei Zhang; Narasimhan P Agaram; William Travis; Samuel Singer; William D Tap; Cristina R Antonescu
Journal:  Mod Pathol       Date:  2019-09-19       Impact factor: 7.842

5.  EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene.

Authors:  Cristina R Antonescu; Lei Zhang; Ning-En Chang; Bruce R Pawel; William Travis; Nora Katabi; Morris Edelman; Andrew E Rosenberg; G Petur Nielsen; Paola Dal Cin; Christopher D M Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2010-12       Impact factor: 5.006

6.  Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions.

Authors:  Tianhua Guo; Lei Zhang; Ning-En Chang; Samuel Singer; Robert G Maki; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2011-01       Impact factor: 5.006

7.  Observations concerning the pathogenesis of epithelioid hemangioma (angiolymphoid hyperplasia).

Authors:  J F Fetsch; S W Weiss
Journal:  Mod Pathol       Date:  1991-07       Impact factor: 7.842

8.  Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.

Authors:  Cristina R Antonescu; Francois Le Loarer; Juan-Miguel Mosquera; Andrea Sboner; Lei Zhang; Chun-Liang Chen; Hsiao-Wei Chen; Nursat Pathan; Thomas Krausz; Brendan C Dickson; Ilan Weinreb; Mark A Rubin; Meera Hameed; Christopher D M Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2013-06-05       Impact factor: 5.006

9.  A novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma.

Authors:  Charles Walther; Johnbosco Tayebwa; Henrik Lilljebjörn; Linda Magnusson; Jenny Nilsson; Fredrik Vult von Steyern; Ingrid Øra; Henryk A Domanski; Thoas Fioretos; Karolin H Nord; Christopher D M Fletcher; Fredrik Mertens
Journal:  J Pathol       Date:  2014-01-29       Impact factor: 7.996

10.  JNK/AP-1 pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells.

Authors:  Yongmei Yin; Shui Wang; Yujie Sun; Young Matt; Nancy H Colburn; Yongqian Shu; Xiao Han
Journal:  Biomed Pharmacother       Date:  2009-06-09       Impact factor: 6.529

View more
  7 in total

1.  Multidisciplinary, articular surface-preserving treatment strategy for locally aggressive epithelioid hemangioma of the acetabulum employing serial bland transarterial embolization.

Authors:  Salim Abboud; Aashish Bhatt; Irina Pateva; Shahrazad Saab; Meera Hameed; John Healey; Patrick Getty
Journal:  Skeletal Radiol       Date:  2022-01-10       Impact factor: 2.199

Review 2.  The 2020 World Health Organization classification of bone tumors: what radiologists should know.

Authors:  Sinchun Hwang; Meera Hameed; Mark Kransdorf
Journal:  Skeletal Radiol       Date:  2022-07-19       Impact factor: 2.128

3.  A Novel Cryptic t(2;3)(p21;q25) Translocation Fuses the WWTR1 and PRKCE Genes in Uterine Leiomyoma With 3q- as the Sole Visible Chromosome Abnormality.

Authors:  Ioannis Panagopoulos; Kristin Andersen; Ludmila Gorunova; Ben Davidson; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2022 Sep-Oct       Impact factor: 3.395

4.  From FOS fusions to somatic mutations in the MAPK pathway, heterogeneous genetic abnormalities cause distinct pathophysiology among subsets of epithelioid haemangiomas.

Authors:  W Tan; J S Nelson
Journal:  Br J Dermatol       Date:  2022-03-01       Impact factor: 11.113

5.  A novel WWTR1::AFF2 fusion in an intra-abdominal soft tissue sarcoma with associated endometriosis.

Authors:  Nooshin K Dashti; Josephine K Dermawan; J Kenneth Schoolmeester; Kevin C Halling; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2022-04-26       Impact factor: 4.263

Review 6.  The genetics of vascular tumours: an update.

Authors:  Dianne Torrence; Cristina R Antonescu
Journal:  Histopathology       Date:  2022-01       Impact factor: 7.778

7.  A unique epithelioid vascular neoplasm of bone characterized by EWSR1/FUS-NFATC1/2 fusions.

Authors:  Nooshin K Dashti; Brendan C Dickson; Lei Zhang; Ziyu Xie; Gunnlaugur Pétur Nielsen; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2021-08-06       Impact factor: 5.006

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.